These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25602103)

  • 1. UK Early Access to Medicines Scheme.
    Burki TK
    Lancet Oncol; 2014 Nov; 15(12):e531. PubMed ID: 25602103
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunotherapy in glioblastoma: emerging options in precision medicine.
    Hodges TR; Ferguson SD; Heimberger AB
    CNS Oncol; 2016 Jul; 5(3):175-86. PubMed ID: 27225028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promising vaccines for treating glioblastoma.
    Swartz AM; Shen SH; Salgado MA; Congdon KL; Sanchez-Perez L
    Expert Opin Biol Ther; 2018 Nov; 18(11):1159-1170. PubMed ID: 30281978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme.
    Polivka J; Polivka J; Holubec L; Kubikova T; Priban V; Hes O; Pivovarcikova K; Treskova I
    Anticancer Res; 2017 Jan; 37(1):21-33. PubMed ID: 28011470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine-Based Immunotherapeutics for the Treatment of Glioblastoma: Advances, Challenges, and Future Perspectives.
    Cuoco JA; Benko MJ; Busch CM; Rogers CM; Prickett JT; Marvin EA
    World Neurosurg; 2018 Dec; 120():302-315. PubMed ID: 30196171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early-access scheme picks controversial glioblastoma vaccine.
    Elvidge S
    Nat Biotechnol; 2014 Dec; 32(12):1179. PubMed ID: 25489829
    [No Abstract]   [Full Text] [Related]  

  • 7. Glioblastoma antigen discovery--foundations for immunotherapy.
    Azad TD; Razavi SM; Jin B; Lee K; Li G
    J Neurooncol; 2015 Jul; 123(3):347-58. PubMed ID: 26045361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solving the riddle of glioblastoma: The hope for immunotherapy.
    Bashir R; Mohile NA
    Neurology; 2016 Jun; 86(24):2220-1. PubMed ID: 27225224
    [No Abstract]   [Full Text] [Related]  

  • 9. Chimeric antigen receptor T-cell immunotherapy for glioblastoma: practical insights for neurosurgeons.
    Choi BD; Curry WT; Carter BS; Maus MV
    Neurosurg Focus; 2018 Jun; 44(6):E13. PubMed ID: 29852773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current State of Immune-Based Therapies for Glioblastoma.
    Lim M; Weller M; Chiocca EA
    Am Soc Clin Oncol Educ Book; 2016; 35():e132-9. PubMed ID: 27249715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell therapy targets glioblastoma.
    Cancer Discov; 2015 May; 5(5):458. PubMed ID: 25783861
    [No Abstract]   [Full Text] [Related]  

  • 12. Dendritic cell immunotherapy for glioblastoma.
    Polyzoidis S; Ashkan K
    Expert Rev Anticancer Ther; 2014 Jul; 14(7):761-3. PubMed ID: 24850137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining immunotherapy with radiation for the treatment of glioblastoma.
    Chow KK; Hara W; Lim M; Li G
    J Neurooncol; 2015 Jul; 123(3):459-64. PubMed ID: 25877468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy for glioblastoma: a long and winding road.
    Weller M
    Neuro Oncol; 2010 Apr; 12(4):319. PubMed ID: 20308309
    [No Abstract]   [Full Text] [Related]  

  • 15. The intersection between genetic engineering and immunotherapy: taking a BiTE out of glioblastoma.
    Njoku I; Boockvar JA
    Neurosurgery; 2013 Jun; 72(6):N16-7. PubMed ID: 23685511
    [No Abstract]   [Full Text] [Related]  

  • 16. How immunotherapies are targeting the glioblastoma immune environment.
    Felthun J; Reddy R; McDonald KL
    J Clin Neurosci; 2018 Jan; 47():20-27. PubMed ID: 29042147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current challenges in designing GBM trials for immunotherapy.
    Weathers SP; Gilbert MR
    J Neurooncol; 2015 Jul; 123(3):331-7. PubMed ID: 25577401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New perspectives in glioma immunotherapy.
    Daga A; Bottino C; Castriconi R; Gangemi R; Ferrini S
    Curr Pharm Des; 2011; 17(23):2439-67. PubMed ID: 21827420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy and radiation in glioblastoma.
    Sahebjam S; Sharabi A; Lim M; Kesarwani P; Chinnaiyan P
    J Neurooncol; 2017 Sep; 134(3):531-539. PubMed ID: 28567588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomegalovirus-targeted immunotherapy and glioblastoma: hype or hope?
    Ferguson SD; Srinivasan VM; Ghali MG; Heimberger AB
    Immunotherapy; 2016; 8(4):413-23. PubMed ID: 26973123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.